vidarabine has been researched along with Albinism, Cutaneous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Ahmari, A; Al-Dhekri, H; Al-Jefri, A; Al-Mofareh, M; Al-Mousa, H; Al-Muhsen, S; Al-Saud, B; Al-Seraihy, A; Al-Sweedan, S; Alsaedi, H; Arnaout, R; Ayas, M; El-Solh, H; Ghemlas, I; Mohammed, R; Siddiqui, K | 1 |
| Behfar, M; Fazlollahi, MR; Ghavamzadeh, A; Hamidieh, AA; Hashemi, S; Moin, M; Pourpak, Z; Yari, K | 1 |
2 other study(ies) available for vidarabine and Albinism, Cutaneous
| Article | Year |
|---|---|
Hematopoietic stem cell transplantation in children with Griscelli syndrome type 2: a single-center report on 35 patients.
Topics: Busulfan; Child; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Neoplasm Recurrence, Local; Piebaldism; Primary Immunodeficiency Diseases; Retrospective Studies; Transplantation Conditioning; Vidarabine | 2020 |
Hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen in pediatric patients with Griscelli syndrome type 2.
Topics: Child, Preschool; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immune System; Immunologic Deficiency Syndromes; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Myeloablative Agonists; Piebaldism; Primary Immunodeficiency Diseases; Prospective Studies; Tissue Donors; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2013 |